"聪明钱"流向曝光！暗盘资金破解主力操盘密码>> 乳品板块再度拉升，贝因美（002570）涨停，品渥食品（300892）、骑士乳业、熊猫乳品（300898）、 一鸣食品（605179）、皇氏集团（002329）等纷纷走高。 ...

Core Insights - The dairy industry is experiencing a significant downturn in 2024, with 19 listed dairy companies in A-shares reporting a total revenue of 184.83 billion yuan, a year-on-year decrease of 7.44% [1] - The net profit attributable to shareholders dropped from 13.10 billion yuan to 9.58 billion yuan, with 13 companies reporting a decline in net profit [1] - Key factors suppressing the dairy industry include oversupply, weakened demand, and high inventory levels, leading to a continuous decline in fresh milk prices and intensified competition [1] Revenue and Profitability - 14 out of 19 dairy companies reported a decline in revenue, compared to only 6 the previous year [1] - The median net profit margin for listed dairy companies was only 1.98%, down 2.01 percentage points from the previous year [4] - The highest net profit margins were recorded by Sunshine Dairy (21.84%), Panda Dairy (13.32%), and Huirong Technology (10.18%) [4] Gross Margin Analysis - 12 companies experienced a decline in gross margin, with the most significant drops seen in Western Pastoral, Beingmate, and Zhuangyuan Pastoral [3] - The median gross margin for the 19 listed dairy companies was 25.31%, an increase of 2.18 percentage points from the previous year [2] - Seven companies saw an increase in gross margin, with the most notable improvements from Junyao Health, Huangshi Group, Panda Dairy, and Pinwa Food [2] Market Trends - The dairy industry index has seen a decline of over 50% from its peak in January 2021 to the low in September 2024, but there has been a noticeable increase since September 2024 [1] - The market anticipates that upstream destocking will lead to a bottoming out of raw milk prices, alongside policies promoting fertility to boost demand [1] Company-Specific Performance - Panda Dairy, a leader in the condensed milk segment, reported a revenue decline of 19.29% last year, with a further 8.27% drop in the first quarter of 2024, despite an increase in gross margin due to lower raw material costs [2] - Bright Dairy, a typical regional dairy company, has seen a decline in revenue since 2022, with a low gross margin of around 19%, significantly below that of Yili [5]

关于第二期股票期权激励计划之股票期权注销完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 贝因美股份有限公司（以下简称"公司"）于 2025 年 4 月 27 日召开第九届 董事会第八次会议、第九届监事会第八次会议，审议通过了《关于第二期股票期 权激励计划未达到行权条件暨注销相关股票期权的议案》，鉴于公司 2024 年实现 经审计营业收入 27.73 亿元，净利润 1.03 亿元，两个业绩指标均未达成第二期股 票期权激励计划首次授予部分第三个行权期行权条件和预留部分第二个行权期 行权条件，对应 277 名激励对象对应可行权的股票期权 829.498 万份均不得行权， 由公司注销。 本次注销完成后，公司第二期股票期权激励计划已授予未行权的期权已全部 注销。具体内容详见公司于 2025 年 4 月 29 日披露于指定信息披露媒体及巨潮资 讯网（http://www.cninfo.com.cn）上的《关于第二期股票期权激励计划未达到行 权条件暨注销相关股票期权的公告》（公告编号：2025-028）。 一、本次股票期权注销完成情况 证券代码：002570 证 ...

证券代码：002570 证券简称：贝因美 公告编号：2025-041 贝因美股份有限公司 关于控股股东营业执照相关信息变更并完成工商变更登记 的公告 贝因美股份有限公司（以下简称"公司"）于今日接到公司控股股东浙江小 贝大美控股有限公司（曾用名：贝因美集团有限公司）通知，获悉其公司名称及 营业执照相关登记信息发生了变更，上述变更事项已完成工商变更登记，并取得 由金华市金东区市场监督管理局核发的《营业执照》。具体如下： 一、控股股东更名后的《营业执照》信息 名称：浙江小贝大美控股有限公司 统一社会信用代码：91330108751714725W 注册资本：贰亿壹仟贰佰柒拾肆万元整 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 类型：有限责任公司（自然人投资或控股） 成立日期：2003 年 7 月 15 日 法定代表人：李晓京 住所：浙江省金华市金东区多湖街道宾虹东路 299 号浙中总部经济中心 1# 楼主楼幢 2603 室 经营范围：一般项目：控股公司服务；医护人员防护用品批发；医用口罩批 发；第二类医疗器械销售；日用口罩（非医用）销售；个人卫生用品销售；卫生 ...

乳业板块午后拉升，品渥食品（300892）、骑士乳业涨超9%，熊猫乳品（300898）涨超5%，西部牧业 （300106）、贝因美（002570）跟涨。 ...

Group 1: Company Strategy and Growth Plans - The company is committed to a stock repurchase plan, reflecting confidence in its investment value [2] - In response to declining birth rates in China, the company plans to enhance revenue and maintain profit growth by expanding its product offerings, including snacks and diapers for children aged 0-3, and adult nutrition products [2][3] - The new strategy "Only Earn 5%" refers to a net profit margin, focusing on cost control, supply chain optimization, and product quality assurance [3] Group 2: Market and Policy Response - The company is closely monitoring national and local fertility support policies, believing these will stimulate market activity and support the development of its maternal and infant ecosystem business [4] - The company has reduced the number of distributors by 230 in 2024 to improve distributor quality and ensure a solid customer base for sustained growth [5] Group 3: Financial Performance and Product Segmentation - Adult powder revenue currently accounts for approximately 8% of total milk powder revenue, with expectations for growth in this segment through the introduction of more suitable products [5]

出品丨搜狐财经 作者丨 饶婷 编辑丨李文贤 5月13日，贝因美在线上举办2024年度业绩说明会，重点回应了公司回购进展及股价波动。 贝因美方面表示，对公司价值具有强烈的信心，股票回购计划的开展将按照公司的既定步骤，希望投资者理性看待二级市场的价格波动。 对此，贝因美董事、董事会秘书、财务总监金志强表示，对公司价值具有强烈的信心，股票回购计划的开展将按照公司的既定步骤。 截至5月13日收盘，贝因美股价为5.92元/股，当日跌幅2.47%，目前总市值63.94亿元。 当被问及公司对现在的股价有何看法，贝因美董事长、总经理谢宏强调，对公司价值有坚定的信心，将通过持续稳健的经营发展，不断提升企业价值，请大 家理性看待二级市场的价格波动。 截至5月13日收盘，贝因美股价为5.92元/股，当日跌幅2.47%，目前总市值63.94亿元。 当被问及公司股权冻结问题，贝因美董事长、总经理谢宏回应称，"大股东债务问题正在积极解决中"。 股票按既定步骤回购，"大股东债务问题正在积极解决中" 贝因美的回购进展和股价波动成为投资者最关注的话题。 据悉，4月29日，贝因美发布公告称，拟以集中竞价交易方式回购股票，用于未来实施的股权激励或 ...

关于参加 2025 年浙江辖区上市公司投资者网上集体接待日暨 2024 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 贝因美股份有限公司（以下简称"公司"）2024 年年度报告已于 2025 年 4 月 29 日披露，为进一步加强与投资者的互动交流，公司将参加由浙江证监局指 导，浙江上市公司协会主办，深圳市全景网络有限公司承办的"2025 年浙江辖 区上市公司投资者网上集体接待日暨 2024 年度业绩说明会"，现将相关事项公 告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流。活动时间为 2025 年 5 月 13 日（周二）15:00-17:00。届时公司 董事长兼总经理谢宏、独立董事俞春萍、董事会秘书兼财务总监金志强（如遇特 殊情况，参会人员将有调整）将在线就公司 2024 年度业绩、公司治理、发展战 略、经营状况、股权激励和可持续发展等投资者关心的问题，与投资者进行沟通 与交流，欢迎广大投资者踊跃 ...

Core Viewpoint - Beiyinmei reported a strong financial performance in 2024, with significant growth in revenue and net profit, driven by a solid foundation in infant formula and rapid growth in new product categories [1][2]. Financial Performance - In 2024, Beiyinmei achieved a revenue of 2.773 billion yuan, a year-on-year increase of 9.7% - The net profit attributable to shareholders reached 103 million yuan, a substantial increase of 116.92% - In Q1 2025, revenue continued to grow, reaching 728 million yuan, up 1.01% year-on-year, with net profit of 43 million yuan, up 93.87% [1]. Industry Dynamics - The infant formula industry in China is experiencing increased concentration, with market share shifting towards leading companies due to new national standards [2]. - Beiyinmei has established a comprehensive industry chain covering R&D, production, and sales, supported by modern production facilities and advanced management systems [2]. Product Strategy - Beiyinmei is pursuing a diversified strategy with three main business directions: maternal and infant ecology, family nutrition, and quality living [3]. - The company is expanding its product offerings to include children's powder, adult powder, complementary foods, and maternal and infant products, with the rice powder segment showing remarkable growth of 111.09% [3]. Sales and Marketing - Beiyinmei employs a multi-channel strategy for sales, enhancing its online presence on platforms like Douyin and Xiaohongshu, while also increasing brand exposure through offline advertising [4]. - The company is focusing on penetrating lower-tier markets as infant formula consumption shifts from first and second-tier cities [4]. Future Outlook - Beiyinmei plans to strengthen R&D in specialized medical foods and functional nutrition products, optimize supply chains, and enhance brand value to address industry challenges [5]. - The company is well-positioned for long-term growth as industry concentration increases and it continues to innovate in products, channels, and branding [5].

Group 1 - The core viewpoint of the news is that a comprehensive financial policy package has been introduced to support the stability of the market and expectations, particularly benefiting the elderly care sector [1][3] - The People's Bank of China has established a 500 billion yuan service consumption and elderly care relending tool to enhance financial support for key areas such as elderly care and service consumption [3] - The elderly care industry in China is projected to reach a scale of 9 trillion yuan in 2022, with expectations to exceed 12 trillion yuan by 2025, indicating a significant growth phase ahead [4][5] Group 2 - The elderly care concept stocks have shown strong performance, with multiple stocks such as Jinming Precision Machinery and Xinhua Jin experiencing significant price increases, some reaching the daily limit [2] - The new policy tool is an expansion and upgrade of the previous inclusive elderly care relending policy, which had a smaller quota of 40 billion yuan and was initially piloted [3] - The silver economy is expected to grow substantially, with projections indicating it could reach 30 trillion yuan by 2035, accounting for 10% of GDP, driven by various sectors including elderly services and health care [4]